Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma.
Weaver C, Bin Satter K, Richardson KP, Tran LKH, Tran PMH, Purohit S. Weaver C, et al. Among authors: richardson kp. Biomedicines. 2022 Nov 17;10(11):2953. doi: 10.3390/biomedicines10112953. Biomedicines. 2022. PMID: 36428521 Free PMC article. Review.
Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions.
Weaver C, Nam A, Settle C, Overton M, Giddens M, Richardson KP, Piver R, Mysona DP, Rungruang B, Ghamande S, McIndoe R, Purohit S. Weaver C, et al. Among authors: richardson kp. Cancers (Basel). 2024 Apr 24;16(9):1629. doi: 10.3390/cancers16091629. Cancers (Basel). 2024. PMID: 38730581 Free PMC article. Review.
High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.
Brzezinska B, Mysona DP, Richardson KP, Rungruang B, Hopkins D, Bearden G, Higgins R, Johnson M, Satter KB, McIndoe R, Ghamande S, Purohit S. Brzezinska B, et al. Among authors: richardson kp. Gynecol Oncol. 2023 Dec;179:1-8. doi: 10.1016/j.ygyno.2023.10.009. Epub 2023 Oct 19. Gynecol Oncol. 2023. PMID: 37862814
Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer.
Mysona DP, Purohit S, Richardson KP, Suhner J, Brzezinska B, Rungruang B, Hopkins D, Bearden G, Higgins R, Johnson M, Bin Satter K, McIndoe R, Ghamande S. Mysona DP, et al. Among authors: richardson kp. Sci Rep. 2023 Nov 27;13(1):20933. doi: 10.1038/s41598-023-47983-z. Sci Rep. 2023. PMID: 38016985 Free PMC article.